ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 114 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2015. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $36 | -100.0% | 22,693 | +389.4% | 0.00% | -100.0% |
| Q1 2018 | $335,000 | -26.9% | 4,637 | -33.4% | 0.00% | -33.3% |
| Q4 2017 | $458,000 | +2594.1% | 6,961 | +300.7% | 0.00% | – |
| Q2 2016 | $17,000 | -34.6% | 1,737 | +14.1% | 0.00% | – |
| Q1 2016 | $26,000 | +4.0% | 1,523 | +35.3% | 0.00% | – |
| Q4 2015 | $25,000 | -30.6% | 1,126 | -25.4% | 0.00% | – |
| Q3 2015 | $36,000 | -7.7% | 1,510 | +217.9% | 0.00% | – |
| Q2 2015 | $39,000 | +34.5% | 475 | +54.2% | 0.00% | – |
| Q1 2015 | $29,000 | +141.7% | 308 | +3.4% | 0.00% | – |
| Q4 2014 | $12,000 | – | 298 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |